Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupninder Sandhu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Breast Cancer Research and Treatment|March 2, 2011
Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3bRupninder Sandhu, Ashley G Rivenbark, William B Coleman
International Journal of Oncology|June 6, 2012
Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell linesRupninder Sandhu, Ashley G Rivenbark, William B Coleman
The American Journal of Pathology|December 27, 2014
Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer methylome for improved therapyRupninder Sandhu, J Devon Roll, Ashley G Rivenbark, et al.
Human Pathology|January 17, 2016
Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stromaRupninder Sandhu, Lynn Chollet-Hinton, Erin L Kirk, et al.
International Journal of Oncology|December 4, 2013
Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancerRupninder Sandhu, Ashley G Rivenbark, Randi M Mackler, et al.
Carcinogenesis|August 16, 2014
Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 statusRupninder Sandhu, Jessica Rein, Monica D'Arcy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2014
Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expressionXuezheng Sun, Rupninder Sandhu, Jonine D Figueroa, et al.
Biophysical Journal|April 28, 2016
Imaging Extracellular Matrix Remodeling In Vitro by Diffusion-Sensitive Optical Coherence TomographyRichard L Blackmon, Rupninder Sandhu, Brian S Chapman, et al.
Experimental and Molecular Pathology|September 19, 2013
Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylationJ Devon Roll, Ashley G Rivenbark, Rupninder Sandhu, et al.
Plos One|April 19, 2018
Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissueXuezheng Sun, Delisha A Stewart, Rupninder Sandhu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|March 2, 2011
Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3bRupninder Sandhu, Ashley G Rivenbark, William B Coleman
International Journal of Oncology|June 6, 2012
Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell linesRupninder Sandhu, Ashley G Rivenbark, William B Coleman
The American Journal of Pathology|December 27, 2014
Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer methylome for improved therapyRupninder Sandhu, J Devon Roll, Ashley G Rivenbark, et al.
Human Pathology|January 17, 2016
Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stromaRupninder Sandhu, Lynn Chollet-Hinton, Erin L Kirk, et al.
International Journal of Oncology|December 4, 2013
Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancerRupninder Sandhu, Ashley G Rivenbark, Randi M Mackler, et al.
Carcinogenesis|August 16, 2014
Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 statusRupninder Sandhu, Jessica Rein, Monica D'Arcy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2014
Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expressionXuezheng Sun, Rupninder Sandhu, Jonine D Figueroa, et al.
Biophysical Journal|April 28, 2016
Imaging Extracellular Matrix Remodeling In Vitro by Diffusion-Sensitive Optical Coherence TomographyRichard L Blackmon, Rupninder Sandhu, Brian S Chapman, et al.
Experimental and Molecular Pathology|September 19, 2013
Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylationJ Devon Roll, Ashley G Rivenbark, Rupninder Sandhu, et al.
Plos One|April 19, 2018
Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissueXuezheng Sun, Delisha A Stewart, Rupninder Sandhu, et al.
Pageof 2